FOXP3

From Wikipedia, the free encyclopedia

forkhead box P3
Identifiers
Symbol FOXP3 IPEX
HUGO 6106
Entrez 50943
OMIM 300292
RefSeq NM_014009
UniProt Q9BZS1
Other data
Locus Chr. X p11.23

Foxp3 is a member of the forkhead/winged-helix family of transcriptional regulators and functions as the master regulator in the development and function of regulatory T cells.

Contents

Human FOXP3 genes contain 11 coding exons. Exon-intron boundaries are identical across the coding regions of the mouse and human genes. By genomic sequence analysis, the FOXP3 gene maps to chromosome Xp11.23.

Foxp3 gene is mutated in the X-linked syndrome of immunodysregulation, polyendocrinopathy, and enteropathy (IPEX) [1]

These mutations were in the forkhead domain of FOXP3, indicating that the mutations may disrupt critical DNA interactions. In mice, a Foxp3 mutation (a frameshift mutation that result in protein lacking the forkhead domain) is responsible for 'Scurfy', an X-linked recessive mouse mutant that results in lethality in hemizygous males 16 to 25 days after birth.[2]

These mice have overproliferation of CD4+ T lymphocytes, extensive multiorgan infiltration, and elevation of numerous cytokines. This phenotype is similar to those that lack expression of CTLA-4, TGF-β, human disease IPEX, or deletion of the Foxp3 gene in mice ("scurfy mice"). The pathology observed in scurfy mice seems to result from an inability to properly regulate CD4+ T-cell activity.

In mice overexpressing the Foxp3 gene, fewer T cells are observed. The remaining T cells have poor proliferative and cytolytic responses and poor IL2 production, although thymic development appears normal. Histologic analysis indicates that peripheral lymphoid organs, particularly lymph nodes lack cells.

The discovery of Foxp3 as a specific marker of regulatory T cells has recently led to an explosion of research in the biological properties of regulatory T cells. [3]

In human disease, alterations in numbers of regulatory T cells, and in particular those that express Foxp3, are found in a number of conditions. For example, patients with tumours have a local relative excess of Foxp3 positive T cells which inhibits the body's ability to suppress the formation of cancerous cells.[4]

On the other hand, patients with autoimmune disease such as systemic lupus erythematosus have a relative dysfunction of Foxp3 positive cells.[5]

In animal studies, regulatory T cells that express Foxp3 are critical in the transfer of immune tolerance, so that hopefully in the future this knowledge can be used to prevent transplant graft rejection. The induction or administration of Foxp3 positive T cells has, in animal studies, led to marked reductions in disease severity in models of diabetes, multiple sclerosis, asthma, inflammatory bowel disease, thyroiditis and renal disease.[6]

These discoveries give hope that cellular therapies using foxp3 positive cells may, one day, help overcome these diseases.

  1. ^ Bennett C, Christie J, Ramsdell F, Brunkow M, Ferguson P, Whitesell L, Kelly T, Saulsbury F, Chance P, Ochs H (2001). "The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3". Nat Genet 27 (1): 20-1. PMID 11137993. 
  2. ^ Brunkow M, Jeffery E, Hjerrild K, Paeper B, Clark L, Yasayko S, Wilkinson J, Galas D, Ziegler S, Ramsdell F (2001). "Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse". Nat Genet 27 (1): 68-73. PMID 11138001. 
  3. ^ Hori S, Nomura T, Sakaguchi S (2003). "Control of regulatory T cell development by the transcription factor Foxp3". Science 299 (5609): 1057-61. PMID 12522256. 
  4. ^ Beyer M, Schultze J (2006). "Regulatory T cells in cancer". Blood 108 (3): 804-11. PMID 16861339. 
  5. ^ Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda A, González-Amaro R (2006). "Regulatory T cells in patients with systemic lupus erythematosus". J Autoimmun 27 (2): 110-8. PMID 16890406. 
  6. ^ Suri-Payer E, Fritzsching B (2006). "Regulatory T cells in experimental autoimmune disease". Springer Semin Immunopathol 28 (1): 3-16. PMID 16838180. 

Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.